Cancer Genetics Services For Medical Specialties
-
Manufactured by Veracyte, Inc.based in USA
Veracyte offers customized biomarker testing and analytical services to our biopharmaceutical partners, helping them advance their therapeutic discovery, development and commercialization programs. We do this by leveraging our novel insights into the molecular underpinnings of disease and our extensive experience in drug development. Our immuno-oncology offerings focus on the implications of the ...
-
Manufactured by Veracytebased in FRANCE
From our proprietary biomarkers, our innovated assays solutions, our unique data analysis platforms and our CDx development capabilities, we offer a comprehensive family of biomarker services that enhance your insight into the tumor microenvironment ...
-
based in BELGIUM
Eurofins Genomics offers comprehensive genetic analysis of sample groups. Both single samples as well as batches of several thousand samples can be processed. For example, we offer genotyping for clinical trials according to the Good Laboratory Practice, GLP (OECD Guideline No.1 on the Principles of Good Laboratory Practice (ENV/MC/CHEM(98)17) and in accordance with the ICH Harmonized Tripartite ...
-
Manufactured by CENTOGENE N.V.based in GERMANY
Genetic testing is a type of medical test that identifies changes in genes, inherited from our parents, which we then typically pass on to our children. “Mistakes” in our genes (called “pathogenic variants”) can manifest the disease, and genetic tests may be used to confirm the disease ...
-
based in USA
Decipher Bladder is the only genomic subtyping tool available to physicians in the United States treating patients with locally advanced bladder ...
-
by JADBiobased in USA
If you look up Wikipedia, you’ll read Automated machine learning (AutoML) is the process of automating the process of applying machine learning to real-world problems. AutoML covers the complete pipeline from the raw dataset to the deployable machine learning model. AutoML was proposed as an artificial intelligence-based solution to the ever-growing challenge of applying machine learning. ...
-
Manufactured by SAGA Diagnostics ABbased in SWEDEN
Cancer is caused by changes in a once-normal cell, which accumulates genetic damage and mutations in the cell’s “instruction book”, the DNA, causing the cell to grow and multiply uncontrollably. Today, we know much about the many mutations which can contribute to cancer, some mutations which can be inherited, as well as the many gene mutations which arise randomly and due to ...
-
Manufactured by IMB Dx, Inc.based in SOUTH KOREA
Analysis of cancer-related genes through blood. Through a simple blood draw, key genes related to various cancer types of solid cancers (including gastric, lung, colon, breast, liver, pancreatic, ovarian and uterine cancer, as well as rare cancers such as melanoma and sarcoma) can be tested for somatic ...
-
Manufactured by Creative Biolabsbased in CHINA
The nucleic acid drug, as a novel therapeutic modality, can achieve long-lasting or even curative effects via gene regulations, replacement or editing. They have great potential to treat human diseases such as viral infections, cancers, and genetic ...
-
Manufactured by Foundation Medicine, Inc.based in USA
Foundation Medicine matches patients to precision oncology trials based on genomic alterations, tumor type, and age. Our team of expert curators and genomicists helps facilitate awareness of genomically matched clinical trial options for your ...
-
Manufactured by Grail, Inc.based in USA
Mapping the Landscape of Genomic Cancer Signals in the Blood. The Circulating Cell-free Genome Atlas (CCGA) Study is a prospective, observational, longitudinal, study designed to characterize the landscape of genomic cancer signals in the blood of people with and without cancer. The study has enrolled approximately 15,000 participants across 142 sites in the United States and Canada, and includes ...
-
Manufactured by Veracytebased in FRANCE
Immunogram, Veracyte’s advanced analytics platform, integrates multi-omic data sets and analyzes them into a single per patient view of key biomarker signatures, specific to their own Tumor Microenvironment. This analytics platform delivers valuable insights to improve patient care and help clinical researchers make informed decisions to advance therapeutic and diagnostic ...
-
Manufactured by Veracytebased in FRANCE
Veracyte’s Cancer Immune Atlas allows clinical researchers to maximize the value of the data generated through our Immunogram analysis platform. The Cancer Immune Atlas creates a reference database from individual Immunograms, to generate biomarker maps, assess toxicity and drug response, stratify patients, and develop predictive ...
-
based in CHINA
Burning Rock utilizes our own proprietary large-scale genomic dataset based on personalized analyses of Chinese cancer patients*, ntegrates the experience from multi-dimensional clinical/scientific research and published data, to provide a one-stop cancer genomic data solution for biopharma partners, aiming to speed up precision drug development and reduce the risks. Burning Rock provides ...
-
based in CANADA
While tissue samples are the standard for cancer molecular profiling, tissue can often be challenging to obtain. Surgical biopsy may be risky or impossible, the biopsy procedure may have resulted in insufficient or exhausted tissue, or the sample acquired resulted in poor quality DNA. Whatever the reason, plasma assays can provide a less invasive alternative or complement to tissue assays. Plasma ...
-
based in CANADA
Find It focuses on gene mutations that can be addressed by current FDA-approved therapies. Find It is more than an assay: it’s a complete solution. Canexia Health partners leverage our expert end-to-end support and proprietary technology as well as a focused panel that identifies therapeutic targets for patients, acquired drug resistance mutations, and mutations with prognostic and ...
-
based in FRANCE
Genetic cancer analyses are particularly challenging due to the huge number of de novo variants and the need to combine DNA and RNA data in some cases. This requires a unique set of interpretation tools and specifically tuned ...
-
based in INDIA
ArrayGen offers a range of Next Generation Sequencing (NGS) data analysis for disease association studies, cancer genomics, personalized medicine, agriculture biotechnology and life sciences to help researchers derive meaningful conclusions from their data. We are a team of data analysis experts, bioinformatics tool developers, and life scientists determined to simplify, enhance, and innovate the ...
-
based in INDIA
ArrayGen offers a range of Next Generation Sequencing (NGS) data analysis for disease association studies, cancer genomics, personalized medicine, agriculture biotechnology and life sciences to help researchers derive meaningful conclusions from their data. We are a team of data analysis experts, bioinformatics tool developers, and life scientists determined to simplify, enhance, and innovate the ...
-
Manufactured by MedGenome Inc.based in USA
Profiling the Tumor Microenvironment: Using a genomics based approach to analyze the tumor microenvironment can provide unique insights beyond IHC and FACS methods. OncoPeptTUME deeply interrogates RNA-Seq data sets to produce high resolution mapping of the tumor microenvironment using proprietary cell type specific gene expression signatures. OncoPeptTUME provides a critical assessment of the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you